Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
33.98
-1.12 (-3.19%)
At close: Apr 28, 2026, 4:00 PM EDT
34.40
+0.42 (1.24%)
After-hours: Apr 28, 2026, 7:32 PM EDT
Capricor Therapeutics Employees
Capricor Therapeutics had 231 employees as of December 31, 2025. The number of employees increased by 71 or 44.38% compared to the previous year.
Employees
231
Change (1Y)
71
Growth (1Y)
44.38%
Revenue / Employee
n/a
Profits / Employee
-$454,736
Market Cap
1.97B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 767 |
| Adaptive Biotechnologies | 624 |
| Ocular Therapeutix | 325 |
| Syndax Pharmaceuticals | 298 |
| Zymeworks | 264 |
| Stoke Therapeutics | 170 |
| Aurinia Pharmaceuticals | 128 |
CAPR News
- 6 weeks ago - Capricor Therapeutics Stock Slides As Q4 Earnings Miss Estimates - Benzinga
- 6 weeks ago - Capricor Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy - GlobeNewsWire
- 7 weeks ago - Capricor Therapeutics Stock Jumps As FDA Resumes Deramiocel Review - Benzinga
- 7 weeks ago - Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA - GlobeNewsWire
- 7 weeks ago - What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday? - Benzinga
- 4 months ago - Capricor Therapeutics Transcript: Study Result - Transcripts